OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alzheimer’s disease as a viral disease: Revisiting the infectious hypothesis
Francesco Bruno, Paolo Abondio, Rossella Bruno, et al.
Ageing Research Reviews (2023) Vol. 91, pp. 102068-102068
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Viral Infections, Are They a Trigger and Risk Factor of Alzheimer’s Disease?
Meagan D. Rippee‐Brooks, Wenzhe Wu, Jianli Dong, et al.
Pathogens (2024) Vol. 13, Iss. 3, pp. 240-240
Open Access | Times Cited: 13

Virology—The next fifty years
Edward C. Holmes, Florian Krammer, Felicia Goodrum
Cell (2024) Vol. 187, Iss. 19, pp. 5128-5145
Open Access | Times Cited: 10

Immunological Profile and Markers of Endothelial Dysfunction in Elderly Patients with Cognitive Impairments
Н. В. Гончаров, Polina I. Popova, I. V. Kudryavtsev, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1888-1888
Open Access | Times Cited: 8

Alzheimer's disease and herpes viruses: Current events and perspectives
Biagio Pinchera, Isabella Di Filippo, Federica Cuccurullo, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 3
Closed Access | Times Cited: 6

Molecular mechanisms and therapeutic potential of lithium in Alzheimer’s disease: repurposing an old class of drugs
Yanxin Shen, Meng Zhao, Panpan Zhao, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6

Navigating the GSK-3β inhibitors as versatile multi-target drug ligands in Alzheimer’s disease intervention – A comprehensive review
Nachiket Jitendra Joshi, Rajasekhar Reddy Alavala
Results in Chemistry (2024) Vol. 7, pp. 101500-101500
Open Access | Times Cited: 5

Development of a high-throughput, quantitative platform using human cerebral organoids to study virus-induced neuroinflammation in Alzheimer’s disease
Meagan N. Olson, Pepper Dawes, Liam F. Murray, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

A Brief History of the Progress in Our Understanding of Genetics and Lifestyle, Especially Diet, in the Risk of Alzheimer’s Disease
William B. Grant
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. s1, pp. S165-S178
Open Access | Times Cited: 4

Infection burden, periodontal pathogens, and their interactive association with incident all‐cause and Alzheimer's disease dementia in a large national survey
May A. Beydoun, Hind A. Beydoun, William O. Dawson, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 9, pp. 6468-6485
Open Access | Times Cited: 4

The Role of Genetic, Environmental, and Dietary Factors in Alzheimer’s Disease: A Narrative Review
Beyza Mertaş, İffet İpek Boşgelmez
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 3, pp. 1222-1222
Open Access

SARS-CoV-2: A synergy to the Alzheimer’s disease
Khaja Moinuddin Shaik, Deepak Kumar, Pirangi Srikanth, et al.
Journal of NeuroVirology (2025)
Closed Access

Neurologic Complications of Influenza and Potential Protective Vaccine Effects
Ann R. Falsey
Influenza and Other Respiratory Viruses (2025) Vol. 19, Iss. 3
Open Access

High throughput identification of genetic regulators of microglial inflammatory processes in Alzheimer's disease
Christopher L. Cardona, Wei Lai, Joonwon Kim, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access

Neurotropic Viruses as Acute and Insidious Drivers of Aging
Angela Rocchi, Hassen S. Wollebo, Kamel Khalili
Biomolecules (2025) Vol. 15, Iss. 4, pp. 514-514
Open Access

Nanomaterial-based approaches to neurotoxin neutralization in neurodegenerative diseases
Meng Cheng, Yan Dou
Nanomedicine (2025), pp. 1-13
Closed Access

Alzheimer’s Disease: A Study on Natural and Herbal Treatment
Pramod S. Salve, Aditya Ashok Pohankar, S. George, et al.
Research Journal of Pharmacy and Technology (2025), pp. 898-906
Closed Access

Hepatic encephalopathy as an indication or contraindication to liver transplant?
Mette Munk Lauridsen, Jasmohan S. Bajaj
Metabolic Brain Disease (2025) Vol. 40, Iss. 4
Open Access

Viral Infections, a Trigger and Risk Factor of Alzheimer’s Disease?
Meagan D. Rippee‐Brooks, Wenzhe Wu, Jianli Dong, et al.
(2024)
Open Access | Times Cited: 3

Neuro‐HIV—New insights into pathogenesis and emerging therapeutic targets
Dmitri Sviridov, Michael Bukrinsky
The FASEB Journal (2023) Vol. 37, Iss. 12
Open Access | Times Cited: 8

ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer’s Disease: Origins, Progression, and Therapeutic Strategies
Vladimir Volloch, Sophia Rits‐Volloch
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 6036-6036
Open Access | Times Cited: 2

Immune receptors and aging brain
Maja Djurišić
Bioscience Reports (2024) Vol. 44, Iss. 2
Open Access | Times Cited: 1

Changes in the Expression of Proteins Associated with Neurodegeneration in the Brains of Mice after Infection with Influenza A Virus with Wild Type and Truncated NS1
Karin Donátová, Miriam Mladá, Katarína Lopušná, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2460-2460
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top